PMID: 9557691Apr 29, 1998Paper

T-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor use

Journal of Virology
D ScholsE De Clercq

Abstract

The NL4.3 T-cell-line-tropic human immunodeficiency virus type 1 strain is sensitive to the CXC chemokine stromal cell-derived factor 1alpha (SDF-1alpha), the natural ligand for CXC chemokine receptor 4 (CXCR4); the 50% inhibitory concentration (IC50) in MT-4 cells is 130 ng/ml. We generated resistant virus through passaging of the virus in the presence of increasing concentrations of SDF-1alpha. After 24 passages, the virus was no longer sensitive to SDF-1alpha (SDF-1alpha(res) virus) (IC50, >2 microg/ml) and became resistant to SDF-1beta (IC50, >2 microg/ml) and to a specific CXCR4 monoclonal antibody (IC50, >20 microg/ml). The SDF-1alpha(res) virus was about 10-fold less sensitive than the wild-type virus to the bicyclam AMD3100, a specific CXCR4 antagonist. The SDF-1alpha(res) virus contained the following mutations in the gp120 molecule: N106K in the V1 loop; S134N and F145L in the V2 loop; F245I in the C2 loop; K269E, Q278H, I288V, and N293D in the V3 loop; a deletion of 5 amino acids (FNSTW) at positions 364 to 368 in the V4 loop; and R378T in the CD4 binding domain. Replication of the NL4.3 wild-type virus and the SDF-1alpha(res) virus was demonstrated in U87 cells that coexpressed CD4 and CXCR4 (U87.CD4.CXCR4) but not ...Continue Reading

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·E De ClercqD Schwartz
Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M BabaE De Clercq
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D ScholsE De Clercq
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·E De ClercqR Datema
Feb 17, 1997·The Journal of Experimental Medicine·R I ConnorN R Landau
Apr 15, 1997·Proceedings of the National Academy of Sciences of the United States of America·A L EdingerR W Doms
Jul 17, 1997·Nature·G AlkhatibK W Peden
Oct 23, 1997·The Journal of Experimental Medicine·D ScholsE De Clercq

❮ Previous
Next ❯

Citations

Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·M L PennL Margolis
Sep 1, 2006·Current Opinion in HIV and AIDS·Dominique Schols
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·M BabaM Fujino
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·P SteinbergerC F Barbas
May 20, 1999·Molecular Membrane Biology·T L Hoffman, R W Doms
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven M DevineJohn F DiPersio
Jun 14, 2003·Journal of Virology·Leonid Gitlin, Raul Andino
Jun 20, 2003·Nature Reviews. Drug Discovery·Erik De Clercq
Mar 5, 2005·Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire·Kohei MiuraBosco M C Chan
Mar 22, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·T Kenakin
Feb 9, 2006·The Journal of Antimicrobial Chemotherapy·Verónica BrizVincent Soriano
Jan 25, 2013·Viruses·Christopher J De Feo, Carol D Weiss
Jan 10, 2008·Molecular Pharmacology·Gemma MoncunillJosé A Esté
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·John P Moore, Robert W Doms
Oct 14, 2008·Infectious Agents and Cancer·Luigi BuonaguroFranco M Buonaguro
Jun 20, 2001·Nature Reviews. Molecular Cell Biology·J P Moore, M Stevenson
Sep 10, 2011·AIDS Research and Human Retroviruses·Maria Espirito-SantoJ Miguel Azevedo-Pereira
Jul 18, 2001·The Journal of General Virology·T Dragic
Jul 2, 2005·Expert Opinion on Emerging Drugs·S Redshaw, M Westby
Mar 7, 2007·Current HIV/AIDS Reports·Kenneth R HenryEric J Arts
Mar 11, 2011·The Journal of Pharmacology and Experimental Therapeutics·Thierry FerainGraeme Fraser
Apr 26, 2008·Journal of Receptor and Signal Transduction Research·Terry Kenakin
Jul 17, 2010·Future Microbiology·Tsutomu Murakami, Naoki Yamamoto
Dec 6, 2011·The Journal of Infectious Diseases·Benoit VisseauxUNKNOWN ANRS CO 05 HIV-2 Cohort
Jan 24, 2003·Expert Opinion on Therapeutic Targets·Lokesh AgrawalLokesh Agrawal
Jan 31, 2003·Expert Opinion on Investigational Drugs·Nobutaka FujiiHirokazu Tamamura
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexandra TrkolaJohn P Moore
Nov 16, 2004·Journal of Virology·Katrien PrincenDominique Schols

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.